Some expert guidelines recommend time-scheduled opioid dosing over pain-contingent dosing for patients receiving chronic opioid therapy (COT). The premise is that time-scheduled dosing results in more stable opioid blood levels and better pain relief, fewer adverse effects, less reinforcement of pain behaviors, and lower addiction risk. We report results of a survey of 1781 patients receiving COT for chronic noncancer pain, in which 967 reported time-scheduled opioid dosing only and 325 reported pain-contingent opioid dosing only. Opioid-related problems and concerns were assessed with the Prescribed Opioids Difficulties Scale. We hypothesized that respondents using time-scheduled opioid dosing would report significantly fewer problems and concerns than those using pain-contingent dosing. Patients receiving time-scheduled dosing received substantially higher average daily opioid doses than those using pain-contingent dosing (97.2 vs. 37.2 mg average daily dose morphine equivalents, P < .0001). Contrary to expectation, time-scheduled opioid dosing was associated with higher levels of patient opioid control concerns than pain-contingent dosing (6.2 vs. 4.8, P = .008), after adjusting for patient and drug regimen differences. Opioid-related psychosocial problems were somewhat greater among patients using time-scheduled dosing, but this difference was nonsignificant after controlling for patient and drug regimen differences (5.9 vs. 5.0, P = .14). Time-scheduled dosing typically involved higher dosage levels and was associated with higher levels of patient concerns about opioid use. Controlled comparative effectiveness research is needed to assess benefits and risks of time-scheduled opioid dosing relative to pain-contingent opioid dosing among COT patients in ambulatory care. Ó
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Introduction
Expert guidelines of the Canadian Pain Society on use of opioid analgesics for chronic noncancer pain [9] state, ''When prescribing an opioid analgesic for around-the-clock pain, it should also be dosed around-the-clock in a pharmacologically appropriate, timecontingent dosing schedule.'' Guidelines for managing persistent pain of the American Geriatric Society also recommend time-scheduled opioid dosing [1] . Possible advantages of time-scheduled dosing cited by these guidelines include: more stable opioid blood levels, increased tolerance to adverse effects, lower addiction risk, reduced reinforcement of pain behaviors, and improved pain control. In contrast, chronic opioid therapy (COT) guidelines of the American Pain Society [5] do not make a recommendation regarding either pain-contingent (as-needed) or time-scheduled dosing.
Empirical research on time-scheduled opioid dosing has largely concerned postoperative pain management. A structured review on time-scheduled opioid dosing for postoperative pain management [12] concluded that there is ''sparse empirical work warranting endorsement of this dosing regimen.'' Subsequently, several trials of time-scheduled opioid dosing reported benefits relative to pain-contingent dosing in postoperative pain management [6, 7, 11, 19] . Whether findings for time-scheduled opioid dosing in postoperative pain management translate to COT in ambulatory care settings has not been examined.
Lack of evidence regarding the effectiveness of time-scheduled opioid dosing in ambulatory care is particularly salient given the dramatic increase in use of COT in community practice settings [3, 17] . Although COT is advocated by expert guidelines [1,5,9], the supporting evidence is limited to short-term trials characterized by guideline reviews as providing low-quality evidence [1, 5] . Opioid dosing regimens may influence COT benefits and risks, so there is a need to understand the clinical implications of
